Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial

Donanemab, a monthly antibody infusion made by pharmaceutical company Eli Lilly, also significantly reduced brain plaque associated with Alzheimer's disease.

from Health and Science https://ift.tt/TkGo4ym
https://ift.tt/xIdlkYA
https://ift.tt/1WmoJAL